Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract
25 Aug 2005 -
Genaissance Pharmaceuticals, Inc. announced that it will provide its high-throughput genotyping services to Biotronics Ltd., headquartered in Nicosia, Cyprus, which has been awarded a contract by the Veterinary Services in the Ministry of Agriculture, Natural Resources & Environment as part of Cyprus' efforts to implement the European Union's (EU) mandate for establishing a breeding program in sheep
that confers resistance to scrapie. Under the terms of the contract, Biotronics will collect the tissue specimens from the Veterinary Services and send them to Genaissance's genotyping facility in New Haven, CT, where Genaissance will analyze a minimum of 100,000 samples over approximately a three-month period of time.
Additional information
Genaissance Pharmaceuticals, Inc. New Haven, CT, United States of America
Top
Contact
Print version
PDF version
Send article
RSS-Feed
